PSIKOSIAREN HASIERAKO FASEAK
Hospital Universitario 12 de Octubre
Madrid, EspañaHospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (20)
2023
-
Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance
European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 6, pp. 1379-1386
2022
-
Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
Journal of Psychiatric Research, Vol. 149, pp. 10-17
-
Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 116
2021
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
-
Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
Frontiers in Pharmacology, Vol. 12
2020
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
-
Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?
Journal of Psychiatry and Neuroscience, Vol. 45, Núm. 5, pp. 322-333
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2018
-
Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: Effect of antidepressants
Journal of Neuroinflammation, Vol. 15, Núm. 1
2017
-
Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia
Neuropharmacology, Vol. 116, pp. 196-207
-
Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422
2016
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575
-
Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia
Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55
2005
-
Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies
Journal of Neural Transmission, Vol. 112, Núm. 4, pp. 557-563
-
Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain
Neuropharmacology, Vol. 49, Núm. 5, pp. 618-626
-
κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice
European Journal of Neuroscience, Vol. 22, Núm. 8, pp. 2106-2110
2004
-
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
Neuropharmacology, Vol. 46, Núm. 7, pp. 966-973
-
Role of endocannabinoid system in mental diseases
Neurotoxicity Research, Vol. 6, Núm. 3, pp. 213-224
2002
-
Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies
Neuroscience Letters, Vol. 333, Núm. 2, pp. 151-153